After the birth of Snuppy, the world’s first cloned dog, a handful of biotech entrepreneurs envisioned a thriving business that would provide grieving dog lovers with genetically identical clones of their deceased pets. In Dog Inc., Pulitzer Prize-winning investigative journalist John Woestendiek exposes the grave folly behind those science-fiction dreams.
Woestendiek travels between the United States and South Korea, following the companies looking to cash in on cloning technology, and their clients, who hope cloning really will approximate resurrection.
Although much of the book focuses on the salacious story of Bernann McKinney, a woman obsessed with cloning her Pit Bull, the strength of Dog Inc. is in Woestendiek’s ability to lay out the science and laboratory politics in a way that’s both accessible and engaging. Readers will understand the X-inactivation process that made the first cloned cat so physically distinct from her progenitor — and, consequently, such a public relations failure — as well as the allegations of scientific fraud levied against Woo Suk Hwang, one of the pioneers of canine cloning.
Woestendiek never outright condemns canine cloning, but the details leave little question as to where he falls in the debate. He shines light on the poor treatment of the laboratory dogs used in cloning, the cloned puppies who do not survive the process and the heartbreaking fate of Snuppy himself. As for the actual clones, Dog Inc. tracks kittens, puppies and even a bull cloned at great financial and biological cost, only to prove physically and behaviorally distinct from their genetic parents.
The book serves as a valuable reminder that, like people, our pets are far more than the sum of their DNA.